Sinsin Pharmaceutical Co., Ltd (KOSDAQ: 002800)

Market Cap	81.01B
Revenue (ttm)	105.25B
Net Income (ttm)	4.05B
Shares Out	15.17M
EPS (ttm)	266.49
PE Ratio	20.04
Forward PE	n/a
Dividend	60.00 (1.14%)
Ex-Dividend Date	Dec 27, 2024

Volume	54,400
Open	5,280.00
Previous Close	5,250.00
Day's Range	5,230.00 - 5,380.00
52-Week Range	5,040.00 - 8,100.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About Sinsin Pharmaceutical

Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system. In addition, it exports its products to approximately 30 countries worldwide. The co...

• Industry: Pharmaceutical Preparations
• Founded: 1959
• Employees: 338
• Stock Exchange: KOSDAQ
• Ticker Symbol: 002800

Financial Performance

In 2023, Sinsin Pharmaceutical's revenue was 102.59 billion, an increase of 11.60% compared to the previous year's 91.93 billion. Earnings were 4.68 billion, an increase of 6.01%.